abstract |
The invention provides a FGF21 molecule covalently attached to an antibody binding site via a linker, wherein the linker is covalently attached to the side chain of a linking residue within FGF21. The present invention provides various uses of the compounds, including methods of preventing or treating diabetes or diabetes-related conditions. |